ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1792

OA protection in African spiny (Acomys) mice is partially mediated by the gut microbiome and is transferrable to wild-type mice via microbiome transplantation

Gabriella Dyson1, Montana Barrett1, Nicholas Hanebutt1, Aleksander Szymczak2, Cindy Miranda Brawner1, Pratibha Dube3, Padmaja Mehta-d'Souza1, Ashley Siefert4 and Matlock Jeffries2, 1Oklahoma Medical Research Foundation, Oklahoma City, 2Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Edmond, OK, 4University of Kentucky, Lexington, KY

Meeting: ACR Convergence 2025

Keywords: microbiome, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Mounting evidence suggests that gut microbiome shifts may be associated with knee osteoarthritis (OA) development. We have previously shown that gut microbiome transplantation from OA-resistant MRL/MpJ mice into OA-susceptible B6 mice results in robust protection against OA development. In the present study, we evaluated genus Acomys (African spiny mice), also previously shown to be resistant to OA.

Methods: Fresh frozen cecal content from 7 adult male spiny mice was obtained from the University of Kentucky colony (Dr. Seifert). Under sterile conditions, cecal content was diluted in 200uL of 50:50 sterile glycerol and PBS then transplanted via oral gavage into n=8 11-week-old B6 non-Germ-free (SPF) male mice and n=4 11-week-old C57BL6 (B6) Germ-free (GF) male mice in the OMRF gnotobiotic facility. One week later, unilateral destabilization of the medial meniscus (DMM) surgery was performed. Control groups included n=7 B6-SPF-microbiota-into-male GF mice, n=10 male B6-SPF mice, and n=6 male B6-GF mice. Mice were euthanized 8 weeks after DMM and submitted for OARSI histopathologic scoring. For microbiome analysis, cecal DNA was extracted, 16S rRNA gene amplification done, initial analysis performed via QIIME2 amplicon v.2024-10, aligned to the GreenGenes2 reference tree, and differential microbiome analysis performed using Maaslin2 (v.1.16.0). We also analyzed similarities to our previous histologic and microbiome studies of the OA-protected MRL/MpJ mouse strain (n=5 SPF MRL-into-B6 GF, n=12 SPF MRL-into-B6).

Results: Gut microbiome transplantation from spiny mice to SPF B6 mice prior to DMM surgery resulted in substantial protection from histologic OA development (spiny-into-B6 2.9±0.8 vs. B6 control 7.8±0.5, mean summed OARSI score±SEM, P=0.0003, Figure 1A, 1B). We then confirmed this finding by transplanting gut microbial content from spiny mice to GF B6 mice (ordinarily OA protected), where spiny transplantation induced mild OA susceptibility, whereas wild-type B6 cecal transplant did induce OA susceptibility (spiny-into-GF 2.3±0.3, GF control 1.5±0.3, B6-into-GF 11.2±0.9, P=0.053 spiny-into-GF vs. GF control, P=0.003 spiny-into-GF vs. B6-into-GF). In microbiome analysis, substantial differences were present between spiny mice and B6 mice (n=75 differences, q≤0.05). These differences were substantially similar to our previously published MRL-into-B6 transplantation experiments (n=29 in current reanalysis), Figure 2. Indeed, 13 of these microbiome clades were shared in both comparisons, and 11 were similar in direction and magnitude of change (increased in MRL were all increased in spiny and vice-versa).

Conclusion: The gut microbiome of OA-protected spiny mice confers OA protection in wild-type mice following microbiome transplantation. Microbiome differences in spiny mice are largely similar to previous studies of another OA protected strain, MRL/MpJ. Future work should evaluate whether spiny mouse microbiome transplantation also confers OA pain/behavioral protection and the degree to which individual microbiome species contribute to these findings.

Supporting image 1Figure 1: Histologic OA outcomes following microbiome transplantation and DMM

Supporting image 2Figure 2: Cecal microbiome 16S analysis, clade difference overlaps in Spiny (Acomys) vs. B6 and MRL/MpJ vs. B6


Disclosures: G. Dyson: None; M. Barrett: None; N. Hanebutt: None; A. Szymczak: None; C. Miranda Brawner: None; P. Dube: None; P. Mehta-d'Souza: None; A. Siefert: None; M. Jeffries: Being Inc., 1.

To cite this abstract in AMA style:

Dyson G, Barrett M, Hanebutt N, Szymczak A, Miranda Brawner C, Dube P, Mehta-d'Souza P, Siefert A, Jeffries M. OA protection in African spiny (Acomys) mice is partially mediated by the gut microbiome and is transferrable to wild-type mice via microbiome transplantation [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/oa-protection-in-african-spiny-acomys-mice-is-partially-mediated-by-the-gut-microbiome-and-is-transferrable-to-wild-type-mice-via-microbiome-transplantation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/oa-protection-in-african-spiny-acomys-mice-is-partially-mediated-by-the-gut-microbiome-and-is-transferrable-to-wild-type-mice-via-microbiome-transplantation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology